Skip Navigation
National Institutes of Health: National Cancer Institute: Division of Cancer Control and Population Sciences
Grant Details

Grant Number: 7R01CA139020-03 Interpret this number
Primary Investigator: Bondy, Melissa
Organization: Baylor College Of Medicine
Project Title: International Case Control Study of Malignant Glioma
Fiscal Year: 2012
Back to top


Abstract

DESCRIPTION (provided by applicant): Glioma comprises about 40% of all primary brain tumors accounting for as many as 26,000 U.S. and European deaths annually. Inherited susceptibility plays a role with 2-fold increased risk of glioma among first-degree relatives of glioma cases. We initiated a multi-center, international linkage study: "Genetic Epidemiology of Glioma International Consortium" in 2007 to address the role of inherited susceptibility. Since this study does not allow us currently to address the role of genetic susceptibility in sporadic cases, we propose this case- control study to address this gap. Members of the consortium have conducted genome wide association studies (GWAS) that will be the discovery phase (phase I). While of high value for discovery, we propose to recruit 6,000 newly diagnosed glioma cases and 6,000 age-gender-ethnicity-matched controls, and collect detailed epidemiologic data and biologic samples from the 13 participating Gliogene sites. We hypothesize that novel inherited variation influencing the susceptibility to glioma can be identified by high density SNP analysis, and propose the following specific aims: SA1: Identify common genetic variants contributing to the risk of glioma. We plan to conduct phases 2 and 3 of the 3 phase approach, specifically we will: (SA1a) Validate GWAS findings from the discovery sets, and replicate the top hits (~23,000 SNPs) with lowest p- values from the two phase GWA studies in a series of 2,000 cases and 2,000 controls (phase 2, validation). Validate the top hits from the test set (aim 1a). From stage 2, genes with SNPs displaying an association at pd10-4 (including the complete haplotype tagging - approximately 100 SNPs) will then be genotyped in a further series of 4,000 cases and 4,000 controls (stage 3, validation). SNPs significant at 10-7 or better will be considered in the final analyses. (SA1b). Using an a priori hypothesis that DNA repair in inflammation contribute to glioma risk, we will selectively interrogate DNA repair and inflammation pathway genes using data for select genes derived from the high-density array. We will conduct a hypothesis driven genetic association in DNA repair and in inflammation/immune function related genes with glioma risk using functional genomic and bioinformatic tools to interrogate available databases. (SA2): Evaluate gene-gene (G-G) and gene- environmental (G-E) interactions with strong biologic relevance to identify G-G and G-E interactions for glioma risk using machine-learning tools (MDR, FITF, and CART) in these exploratory analyses. There are no existing glioma case-control studies with sufficient numbers of biological samples and common epidemiologic data to conduct a comprehensive validation and replication study, or to address the issues of tumor heterogeneity as we will in this study. PUBLIC HEALTH RELEVANCE: Gliomas are a rare and understudied disease that is rapidly fatal. The proposed case-control study of primary malignant glioma (Gliogene Consortium) includes 13-centers, and will address the role of genetic susceptibility in sporadic cases. It will identify common genetic variants contributing to the risk of glioma from a genome wide association study.

Back to top


Publications

Genetic Advances In Glioma: Susceptibility Genes And Networks
Authors: Liu Y. , Shete S. , Hosking F. , Robertson L. , Houlston R. , Bondy M. .
Source: Current Opinion In Genetics & Development, 2010 Jun; 20(3), p. 239-44.
PMID: 20211558
Related Citations

Hmg Coa Reductase Inhibitors, Nsaids And Risk Of Glioma
Authors: Ferris J.S. , McCoy L. , Neugut A.I. , Wrensch M. , Lai R. .
Source: International Journal Of Cancer, 2012-09-15 00:00:00.0; 131(6), p. E1031-7.
PMID: 22419506
Related Citations

Genome-wide Methylation Analyses In Glioblastoma Multiforme
Authors: Lai R.K. , Chen Y. , Guan X. , Nousome D. , Sharma C. , Canoll P. , Bruce J. , Sloan A.E. , Cortes E. , Vonsattel J.P. , et al. .
Source: Plos One, 2014; 9(2), p. e89376.
PMID: 24586730
Related Citations

Exploring The Association Between Melanoma And Glioma Risks
Authors: Scarbrough P.M. , Akushevich I. , Wrensch M. , Il'yasova D. .
Source: Annals Of Epidemiology, 2014 Jun; 24(6), p. 469-74.
PMID: 24703682
Related Citations

Variants Near Tert And Terc Influencing Telomere Length Are Associated With High-grade Glioma Risk
Authors: Walsh K.M. , Codd V. , Smirnov I.V. , Rice T. , Decker P.A. , Hansen H.M. , Kollmeyer T. , Kosel M.L. , Molinaro A.M. , McCoy L.S. , et al. .
Source: Nature Genetics, 2014 Jul; 46(7), p. 731-5.
PMID: 24908248
Related Citations

A Comparison Of Dna Methylation Specific Droplet Digital Pcr (ddpcr) And Real Time Qpcr With Flow Cytometry In Characterizing Human T Cells In Peripheral Blood
Authors: Wiencke J.K. , Bracci P.M. , Hsuang G. , Zheng S. , Hansen H. , Wrensch M.R. , Rice T. , Eliot M. , Kelsey K.T. .
Source: Epigenetics, 2014 Oct; 9(10), p. 1360-5.
PMID: 25437051
Related Citations

Serum Macrophage-derived Chemokine/ccl22 Levels Are Associated With Glioma Risk, Cd4 T Cell Lymphopenia And Survival Time
Authors: Zhou M. , Bracci P.M. , McCoy L.S. , Hsuang G. , Wiemels J.L. , Rice T. , Zheng S. , Kelsey K.T. , Wrensch M.R. , Wiencke J.K. .
Source: International Journal Of Cancer, 2015-08-15 00:00:00.0; 137(4), p. 826-36.
PMID: 25604093
Related Citations

Cdkn2a Loss Is Associated With Shortened Overall Survival In Lower-grade (world Health Organization Grades Ii-iii) Astrocytomas
Authors: Reis G.F. , Pekmezci M. , Hansen H.M. , Rice T. , Marshall R.E. , Molinaro A.M. , Phillips J.J. , Vogel H. , Wiencke J.K. , Wrensch M.R. , et al. .
Source: Journal Of Neuropathology And Experimental Neurology, 2015 May; 74(5), p. 442-52.
PMID: 25853694
Related Citations

Genetic Modulation Of Neurocognitive Function In Glioma Patients
Authors: Liu Y. , Zhou R. , Sulman E.P. , Scheurer M.E. , Boehling N. , Armstrong G.N. , Tsavachidis S. , Liang F.W. , Etzel C.J. , Conrad C.A. , et al. .
Source: Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research, 2015-07-15 00:00:00.0; 21(14), p. 3340-6.
PMID: 25904748
Related Citations

Glioma Groups Based On 1p/19q, Idh, And Tert Promoter Mutations In Tumors
Authors: Eckel-Passow J.E. , Lachance D.H. , Molinaro A.M. , Walsh K.M. , Decker P.A. , Sicotte H. , Pekmezci M. , Rice T. , Kosel M.L. , Smirnov I.V. , et al. .
Source: The New England Journal Of Medicine, 2015-06-25 00:00:00.0; 372(26), p. 2499-508.
PMID: 26061753
Related Citations

Longer Genotypically-estimated Leukocyte Telomere Length Is Associated With Increased Adult Glioma Risk
Authors: Walsh K.M. , Codd V. , Rice T. , Nelson C.P. , Smirnov I.V. , McCoy L.S. , Hansen H.M. , Elhauge E. , Ojha J. , Francis S.S. , et al. .
Source: Oncotarget, 2015-12-15 00:00:00.0; 6(40), p. 42468-77.
PMID: 26646793
Related Citations

The Glioma International Case-control Study: A Report From The Genetic Epidemiology Of Glioma International Consortium
Authors: Amirian E.S. , Armstrong G.N. , Zhou R. , Lau C.C. , Claus E.B. , Barnholtz-Sloan J.S. , Il'yasova D. , Schildkraut J. , Ali-Osman F. , Sadetzki S. , et al. .
Source: American Journal Of Epidemiology, 2016-01-15 00:00:00.0; 183(2), p. 85-91.
PMID: 26656478
Related Citations

Approaching A Scientific Consensus On The Association Between Allergies And Glioma Risk: A Report From The Glioma International Case-control Study
Authors: Amirian E.S. , Zhou R. , Wrensch M.R. , Olson S.H. , Scheurer M.E. , Il'yasova D. , Lachance D. , Armstrong G.N. , McCoy L.S. , Lau C.C. , et al. .
Source: Cancer Epidemiology, Biomarkers & Prevention : A Publication Of The American Association For Cancer Research, Cosponsored By The American Society Of Preventive Oncology, 2016 Feb; 25(2), p. 282-90.
PMID: 26908595
Related Citations